The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
Update on fibroblast growth factor 23 in chronic kidney disease
Open accessAbstract
Chronic kidney disease (CKD) is a public health epidemic that affects millions of people worldwide. Presence of CKD predisposes individuals to high risks of end-stage renal disease, cardiovascular disease and premature death. Disordered phosphate homeostasis with elevated circulating levels of fibroblast growth factor 23 (FGF23) is an early and pervasive complication of CKD. CKD is likely the most common cause of chronically elevated FGF23 levels, and the clinical condition in which levels are most markedly elevated. Although increases in FGF23 levels help maintain serum phosphate in the normal range in CKD, prospective studies in populations of pre-dialysis CKD, incident and prevalent end-stage renal disease, and kidney transplant recipients demonstrate that elevated FGF23 levels are independently associated with progression of CKD and development of cardiovascular events and mortality. It was originally thought that these observations were driven by elevated FGF23 acting as a highly sensitive biomarker of toxicity due to phosphate. However, FGF23 itself has now been shown to mediate “off-target,” direct, end-organ toxicity in the heart, which suggests that elevated FGF23 may be a novel mechanism of adverse outcomes in CKD. This report reviews recent advances in FGF23 biology relevant to CKD, the classical effects of FGF23 on mineral homeostasis, and the studies that established FGF23 excess as a biomarker and novel mechanism of cardiovascular disease. The report concludes with a critical review of the effects of different therapeutic strategies targeting FGF23 reduction and how these might be leveraged in a future randomized trial aimed at improving outcomes in CKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The environment and disease: association or causation?
Hill, A. B. (2015) · Journal of the Royal Society of Medicine · doi:10.1177/0141076814562718 · Cited by 7,285
The Environment and Disease: Association or Causation?
Hill, A. B. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800503 · Cited by 6,974
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
Wanner, C., Krane, V., März, W., Olschewski, M., Mann, J. F. E., Ruf, G., & Ritz, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043545 · Cited by 2,614
Goodman, W. G., Goldin, J., Kuizon, B. D., Yoon, C., Gales, B., Sider, D., Wang, Y., Chung, J., Emerick, A., Greaser, L., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422003 · Cited by 2,509
Oodman, W. I. G. G., Oldin, J. O. G., Uizon, D. K., Oon, C. H. Y., Ales, B. A. G., Ider, D. O. S., Ang, W. C., Oanie, J., Hung, C., Merick, A. L. E., et al. (2000) · Cited by 2,191
FGF23 induces left ventricular hypertrophy
Faul, C., Amaral, A. P., Oskouei, B., Hu, M.-C., Sloan, A., Isakova, T., Gutiérrez, O. M., Aguillon-Prada, R., Lincoln, J., Hare, J. M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46122 · Cited by 2,027
Self-citationFGF-23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate Homeostasis
Shimada, T., Hasegawa, H., Yamazaki, Y., Muto, T., Hino, R., Takeuchi, Y., Fujita, T., Nakahara, K., Fukumoto, S., & Yamashita, T. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0301264 · Cited by 1,883
Klotho converts canonical FGF receptor into a specific receptor for FGF23
Urakawa, I., Yamazaki, Y., Shimada, T., Iijima, K., Hasegawa, H., Okawa, K., Fujita, T., Fukumoto, S., & Yamashita, T. (2006) · Nature · doi:10.1038/nature05315 · Cited by 1,850
Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
Gutiérrez, O. M., Mannstadt, M., Isakova, T., Rauh-Hain, J. A., Tamez, H., Shah, A., Smith, K., Lee, H., Thadhani, R., Jüppner, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706130 · Cited by 1,727
Self-citationShimada, T., Kakitani, M., Yamazaki, Y., Hasegawa, H., Takeuchi, Y., Fujita, T., Fukumoto, S., Tomizuka, K., & Yamashita, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19081 · Cited by 1,596
Phosphate Regulation of Vascular Smooth Muscle Cell Calcification
Jono, S., McKee, M. D., Murry, C. E., Shioi, A., Nishizawa, Y., Mori, K., Morii, H., & Giachelli, C. M. (2000) · Circulation Research · doi:10.1161/01.res.87.7.e10 · Cited by 1,427
Arterial Calcifications, Arterial Stiffness, and Cardiovascular Risk in End-Stage Renal Disease
Blacher, J., Guerin, A. P., Pannier, B., Marchais, S. J., & London, G. M. (2001) · Hypertension · doi:10.1161/hy1001.096358 · Cited by 1,417
Isakova, T., on behalf of the Chronic Renal Insufficiency Cohort (CRIC) Study Group, Wahl, P., Vargas, G. S., Gutiérrez, O. M., Scialla, J., Xie, H., Appleby, D., Nessel, L., Bellovich, K., et al. (2011) · Kidney International · doi:10.1038/ki.2011.47 · Cited by 1,266
Self-citationCinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
Block, G. A., Martin, K. J., de Francisco, A. L. M., Turner, S. A., Avram, M. M., Suranyi, M. G., Hercz, G., Cunningham, J., Abu-Alfa, A. K., Messa, P., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031633 · Cited by 1,139
Isakova, T. (2011) · JAMA · doi:10.1001/jama.2011.826 · Cited by 1,020
The parathyroid is a target organ for FGF23 in rats
Ben-Dov, I. Z., Galitzer, H., Lavi-Moshayoff, V., Goetz, R., Kuro-o, M., Mohammadi, M., Sirkis, R., Naveh-Many, T., & Silver, J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32409 · Cited by 951
Survival of Patients Undergoing Hemodialysis with Paricalcitol or Calcitriol Therapy
Teng, M., Wolf, M., Lowrie, E., Ofsthun, N., Lazarus, J. M., & Thadhani, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022536 · Cited by 927
Self-citationKlotho Deficiency Causes Vascular Calcification in Chronic Kidney Disease
Hu, M. C., Shi, M., Zhang, J., Quiñones, H., Griffith, C., Kuro-o, M., & Moe, O. W. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009121311 · Cited by 926
Gutierrez, O., Isakova, T., Rhee, E., Shah, A., Holmes, J., Collerone, G., Ju[Combining Diaeresis]ppner, H., & Wolf, M. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010052 · Cited by 921
Self-citationFibroblast Growth Factor 23 in Oncogenic Osteomalacia and X-Linked Hypophosphatemia
Jonsson, K. B., Zahradnik, R., Larsson, T., White, K. E., Sugimoto, T., Imanishi, Y., Yamamoto, T., Hampson, G., Koshiyama, H., Ljunggren, Ö., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020881 · Cited by 914
Reynolds, J. L., Joannides, A. J., Skepper, J. N., McNair, R., Schurgers, L. J., Proudfoot, D., Jahnen-Dechent, W., Weissberg, P. L., & Shanahan, C. M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000141960.01035.28 · Cited by 911
Kalantar-Zadeh, K., Kuwae, N., Regidor, D. L., Kovesdy, C. P., Kilpatrick, R. D., Shinaberger, C. S., McAllister, C. J., Budoff, M. J., Salusky, I. B., & Kopple, J. D. (2006) · Kidney International · doi:10.1038/sj.ki.5001514 · Cited by 905
Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
Gutiérrez, O. M., Januzzi, J. L., Isakova, T., Laliberte, K., Smith, K., Collerone, G., Sarwar, A., Hoffmann, U., Coglianese, E., Christenson, R., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.844506 · Cited by 837
Self-citationVitamin D levels and early mortality among incident hemodialysis patients
Wolf, M., Shah, A., Gutierrez, O., Ankers, E., Monroy, M., Tamez, H., Steele, D., Chang, Y., Camargo, C. A., Tonelli, M., et al. (2007) · Kidney International · doi:10.1038/sj.ki.5002451 · Cited by 789
Self-citationImpact of left ventricular hypertrophy on survival in end-stage renal disease
Silberberg, J. S., Barre, P. E., Prichard, S. S., & Sniderman, A. D. (1989) · Kidney International · doi:10.1038/ki.1989.192 · Cited by 784
Activated Injectable Vitamin D and Hemodialysis Survival: A Historical Cohort Study
Teng, M., Wolf, M., Ofsthun, M. N., Lazarus, J. M., Hernán, M. A., Camargo, C. A., & Thadhani, R. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070573 · Cited by 782
Self-citationFliser, D., Kollerits, B., Neyer, U., Ankerst, D. P., Lhotta, K., Lingenhel, A., Ritz, E., & Kronenberg, F. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080936 · Cited by 699
Larsson, T., Nisbeth, U. L. F., Ljunggren, Ö., Jüppner, H., & Jonsson, K. B. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00328.x · Cited by 689
The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods
Feldman, H. I., Appel, L. J., Chertow, G. M., Cifelli, D., Cizman, B., Daugirdas, J., Fink, J. C., Franklin-Becker, E. D., Go, A. S., Hamm, L. L., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000070149.78399.ce · Cited by 659
FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting
Riminucci, M., Collins, M. T., Fedarko, N. S., Cherman, N., Corsi, A., White, K. E., Waguespack, S., Gupta, A., Hannon, T., Econs, M. J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18399 · Cited by 657
Rapid Loss of Vertebral Mineral Density after Renal Transplantation
Julian, B. A., Laskow, D. A., Dubovsky, J., Dubovsky, E. V., Curtis, J. J., & Quarles, L. D. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108223250804 · Cited by 652
Fibroblast Growth Factor 23 Is a Counter-Regulatory Phosphaturic Hormone for Vitamin D
Liu, S., Tang, W., Zhou, J., Stubbs, J. R., Luo, Q., Pi, M., & Quarles, L. D. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005111185 · Cited by 642
Moe, S. M., Zidehsarai, M. P., Chambers, M. A., Jackman, L. A., Radcliffe, J. S., Trevino, L. L., Donahue, S. E., & Asplin, J. R. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05040610 · Cited by 564
Ferrari, S. L., Bonjour, J.-P., & Rizzoli, R. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1039 · Cited by 518
Pathogenic role of Fgf23 in Hyp mice
Liu, S., Zhou, J., Tang, W., Jiang, X., Rowe, D. W., & Quarles, L. D. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00008.2006 · Cited by 495
Tsujikawa, H., Kurotaki, Y., Fujimori, T., Fukuda, K., & Nabeshima, Y.-I. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0048 · Cited by 491
Endocrine functions of bone in mineral metabolism regulation
Quarles, L. D. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36479 · Cited by 459
Parker, B. D., Schurgers, L. J., Brandenburg, V. M., Christenson, R. H., Vermeer, C., Ketteler, M., Shlipak, M. G., Whooley, M. A., & Ix, J. H. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-10-201005180-00004 · Cited by 457
Regulation of C-Terminal and Intact FGF-23 by Dietary Phosphate in Men and Women
Burnett, S.-A. M., Gunawardene, S. C., Bringhurst, F. R., Jüppner, H., Lee, H., & Finkelstein, J. S. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060507 · Cited by 455
FGF-23 Associates with Death, Cardiovascular Events, and Initiation of Chronic Dialysis
Kendrick, J., Cheung, A. K., Kaufman, J. S., Greene, T., Roberts, W. L., Smits, G., & Chonchol, M. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010121224 · Cited by 448
Lavi-Moshayoff, V., Wasserman, G., Meir, T., Silver, J., & Naveh-Many, T. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00360.2010 · Cited by 441
Shimada, T., Urakawa, I., Yamazaki, Y., Hasegawa, H., Hino, R., Yoneya, T., Takeuchi, Y., Fujita, T., Fukumoto, S., & Yamashita, T. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.12.102 · Cited by 429
Dietary Phosphorus Regulates Serum Fibroblast Growth Factor-23 Concentrations in Healthy Men
Antoniucci, D. M., Yamashita, T., & Portale, A. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0021 · Cited by 421
Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community
Mirza, M. A. I., Larsson, A., Lind, L., & Larsson, T. E. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.01.001 · Cited by 386
Farrow, E. G., Yu, X., Summers, L. J., Davis, S. I., Fleet, J. C., Allen, M. R., Robling, A. G., Stayrook, K. R., Jideonwo, V., Magers, M. J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110905108 · Cited by 380
Lorenz-Depiereux, B., Benet-Pages, A., Eckstein, G., Tenenbaum-Rakover, Y., Wagenstaller, J., Tiosano, D., Gershoni-Baruch, R., Albers, N., Lichtner, P., Schnabel, D., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/499410 · Cited by 379
Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism
Shimada, T., Yamazaki, Y., Takahashi, M., Hasegawa, H., Urakawa, I., Oshima, T., Ono, K., Kakitani, M., Tomizuka, K., Fujita, T., et al. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00474.2004 · Cited by 360
Early Control of PTH and FGF23 in Normophosphatemic CKD Patients: A New Target in CKD-MBD Therapy?
Oliveira, R. B., Cancela, A. L. E., Graciolli, F. G., Dos Reis, L. M., Draibe, S. A., Cuppari, L., Carvalho, A. B., Jorgetti, V., Canziani, M. E., & Moysés, R. M. A. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05420709 · Cited by 357
Serum FGF23 Levels in Normal and Disordered Phosphorus Homeostasis
Weber, T. J., Liu, S., Indridason, O. S., & Quarles, L. D. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.7.1227 · Cited by 354
Left Ventricular Mass in Chronic Kidney Disease and ESRD
Glassock, R. J., Pecoits-Filho, R., & Barberato, S. H. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04860709 · Cited by 352
Jean, G., Terrat, J.-C., Vanel, T., Hurot, J.-M., Lorriaux, C., Mayor, B., & Chazot, C. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp191 · Cited by 351
Hasegawa, H., Nagano, N., Urakawa, I., Yamazaki, Y., Iijima, K., Fujita, T., Yamashita, T., Fukumoto, S., & Shimada, T. (2010) · Kidney International · doi:10.1038/ki.2010.313 · Cited by 341
Mirza, M. A. I., Larsson, A., Melhus, H., Lind, L., & Larsson, T. E. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.05.013 · Cited by 341
Shigematsu, T., Kazama, J. J., Yamashita, T., Fukumoto, S., Hosoya, T., Gejyo, F., & Fukagawa, M. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.04.029 · Cited by 326
Forging Forward with 10 Burning Questions on FGF23 in Kidney Disease
Wolf, M. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009121293 · Cited by 308
Self-citationImel, E. A., Peacock, M., Gray, A. K., Padgett, L. R., Hui, S. L., & Econs, M. J. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1239 · Cited by 303
Elevated Fibroblast Growth Factor 23 is a Risk Factor for Kidney Transplant Loss and Mortality
Wolf, M., Molnar, M. Z., Amaral, A. P., Czira, M. E., Rudas, A., Ujszaszi, A., Kiss, I., Rosivall, L., Kosa, J., Lakatos, P., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010080894 · Cited by 290
Self-citationAssociation of Activated Vitamin D Treatment and Mortality in Chronic Kidney Disease
Kovesdy, C. P. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2007.110 · Cited by 277
Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease
Pereira, R. C., Jűppner, H., Azucena-Serrano, C. E., Yadin, O., Salusky, I. B., & Wesseling-Perry, K. (2009) · Bone · doi:10.1016/j.bone.2009.08.008 · Cited by 272
Komaba, H., Goto, S., Fujii, H., Hamada, Y., Kobayashi, A., Shibuya, K., Tominaga, Y., Otsuki, N., Nibu, K.-I., Nakagawa, K., et al. (2010) · Kidney International · doi:10.1038/ki.2009.414 · Cited by 267
Therapeutic Effects of Anti-FGF23 Antibodies in Hypophosphatemic Rickets/Osteomalacia
Aono, Y., Yamazaki, Y., Yasutake, J., Kawata, T., Hasegawa, H., Urakawa, I., Fujita, T., Wada, M., Yamashita, T., Fukumoto, S., et al. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090509 · Cited by 265
Rhee, Y., Bivi, N., Farrow, E., Lezcano, V., Plotkin, L. I., White, K. E., & Bellido, T. (2011) · Bone · doi:10.1016/j.bone.2011.06.025 · Cited by 262
Association of Oral Calcitriol with Improved Survival in Nondialyzed CKD
Shoben, A. B., Rudser, K. D., de Boer, I. H., Young, B., & Kestenbaum, B. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007111164 · Cited by 254
Galitzer, H., Ben-Dov, I. Z., Silver, J., & Naveh-Many, T. (2010) · Kidney International · doi:10.1038/ki.2009.464 · Cited by 246
Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men
Nishida, Y., Taketani, Y., Yamanaka-Okumura, H., Imamura, F., Taniguchi, A., Sato, T., Shuto, E., Nashiki, K., Arai, H., Yamamoto, H., et al. (2006) · Kidney International · doi:10.1038/sj.ki.5002000 · Cited by 243
Hidden Sources of Phosphorus in the Typical American Diet: Does it Matter in Nephrology?
Uribarri, J., & Calvo, M. S. (2003) · Seminars in Dialysis · doi:10.1046/j.1525-139x.2003.16037.x · Cited by 241
Pathogenesis of vascular calcification in chronic kidney disease
Cozzolino, M., Brancaccio, D., Gallieni, M., & Slatopolsky, E. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00421.x · Cited by 240
FGF23 Elevation and Hypophosphatemia after Intravenous Iron Polymaltose: A Prospective Study
Schouten, B. J., Hunt, P. J., Livesey, J. H., Frampton, C. M., & Soule, S. G. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2396 · Cited by 235
Shimada, T., Urakawa, I., Isakova, T., Yamazaki, Y., Epstein, M., Wesseling-Perry, K., Wolf, M., Salusky, I. B., & Jüppner, H. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1603 · Cited by 229
Self-citationMineral Metabolism and Vascular Damage in Children on Dialysis
Shroff, R. C., Donald, A. E., Hiorns, M. P., Watson, A., Feather, S., Milford, D., Ellins, E. A., Storry, C., Ridout, D., Deanfield, J., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006121397 · Cited by 224
on behalf of the European Uremic Toxin (EUTox) Work Group, Desjardins, L., Liabeuf, S., Renard, C., Lenglet, A., Lemke, H.-D., Choukroun, G., Drueke, T. B., & Massy, Z. A. (2012) · Osteoporosis International · doi:10.1007/s00198-011-1838-0 · Cited by 219
Nakanishi, S., Kazama, J. J., Nii-Kono, T., Omori, K., Yamashita, T., Fukumoto, S., Gejyo, F., Shigematsu, T., & Fukagawa, M. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00184.x · Cited by 209
Ohnishi, M., Nakatani, T., Lanske, B., & Razzaque, M. S. (2009) · Kidney International · doi:10.1038/ki.2009.24 · Cited by 200
Seiler, S., Reichart, B., Roth, D., Seibert, E., Fliser, D., & Heine, G. H. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq309 · Cited by 198
FGF23 Fails to Inhibit Uremic Parathyroid Glands
Canalejo, R., Canalejo, A., Martinez-Moreno, J. M., Rodriguez-Ortiz, M. E., Estepa, J. C., Mendoza, F. J., Munoz-Castaneda, J. R., Shalhoub, V., Almaden, Y., & Rodriguez, M. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009040427 · Cited by 195
Oral active vitamin D is associated with improved survival in hemodialysis patients
Naves-Díaz, M., Álvarez-Hernández, D., Passlick-Deetjen, J., Guinsburg, A., Marelli, C., Rodriguez-Puyol, D., & Cannata-Andía, J. B. (2008) · Kidney International · doi:10.1038/ki.2008.343 · Cited by 195
Post-transplant hypophosphatemia: Tertiary ‘Hyper-Phosphatoninism’?
Bhan, I., Shah, A., Holmes, J., Isakova, T., Gutierrez, O., Burnett, S.-A., Jüppner, H., & Wolf, M. (2006) · Kidney International · doi:10.1038/sj.ki.5001788 · Cited by 194
Self-citationJüppner, H. (2011) · Kidney International · doi:10.1038/ki.2011.27 · Cited by 191
Hsu, H. J., & Wu, M.-S. (2009) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181815498 · Cited by 183
Latest findings in phosphate homeostasis
Prié, D., Torres, P. U., & Friedlander, G. (2009) · Kidney International · doi:10.1038/ki.2008.643 · Cited by 181
Vitamin D receptor controls expression of the anti-aging klotho gene in mouse and human renal cells
Forster, R. E., Jurutka, P. W., Hsieh, J.-C., Haussler, C. A., Lowmiller, C. L., Kaneko, I., Haussler, M. R., & Kerr Whitfield, G. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.09.117 · Cited by 172
FGF-23 Is Elevated by Chronic Hyperphosphatemia
Gupta, A., Winer, K., Econs, M. J., Marx, S. J., & Collins, M. T. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0724 · Cited by 168
Wesseling-Perry, K., Pereira, R. C., Sahney, S., Gales, B., Wang, H.-J., Elashoff, R., Jüppner, H., & Salusky, I. B. (2011) · Kidney International · doi:10.1038/ki.2010.352 · Cited by 168
FGF23–parathyroid interaction: implications in chronic kidney disease
Komaba, H., & Fukagawa, M. (2010) · Kidney International · doi:10.1038/ki.2009.466 · Cited by 165
Isakova, T., Gutierrez, O. M., Smith, K., Epstein, M., Keating, L. K., Juppner, H., & Wolf, M. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq419 · Cited by 165
Self-citationFGF-23: More than a regulator of renal phosphate handling?
Jüppner, H., Wolf, M. S., & Salusky, I. B. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.170 · Cited by 164
Self-citationA rat model of chronic kidney disease-mineral bone disorder
Moe, S. M., Chen, N. X., Seifert, M. F., Sinders, R. M., Duan, D., Chen, X., Liang, Y., Radcliff, J. S., White, K. E., & Gattone, V. H. (2009) · Kidney International · doi:10.1038/ki.2008.456 · Cited by 163
Gross, M., & Ritz, E. (2008) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2008.00454.x · Cited by 162
FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease
Yilmaz, M. I., Sonmez, A., Saglam, M., Yaman, H., Kilic, S., Demirkaya, E., Eyileten, T., Caglar, K., Oguz, Y., Vural, A., et al. (2010) · Kidney International · doi:10.1038/ki.2010.194 · Cited by 162
Gutiérrez, O. M., Wolf, M., & Taylor, E. N. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02740311 · Cited by 161
Self-citationPostprandial Mineral Metabolism and Secondary Hyperparathyroidism in Early CKD
Isakova, T., Gutierrez, O., Shah, A., Castaldo, L., Holmes, J., Lee, H., & Wolf, M. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007060673 · Cited by 160
Self-citationKuro-o, M. (2011) · Kidney International · doi:10.1038/ki.2011.26 · Cited by 159
Litzow, J. R., Lemann, J., & Lennon, E. J. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105530 · Cited by 156
Evenepoel, P., Meijers, B. K. I., de Jonge, H., Naesens, M., Bammens, B., Claes, K. J., Kuypers, D. R. J., & Vanrenterghem, Y. F. C. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01310308 · Cited by 155
FGF-23 as a Predictor of Renal Outcome in Diabetic Nephropathy
Titan, S., Zatz, R., Graciolli, F. G., dos Reis, L. M., Barros, R. T., Jorgetti, V., & Moysés, R. M. A. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04250510 · Cited by 154
Hypophosphatemia induced by intravenous administration of saccharated ferric oxide
Shimizu, Y., Tada, Y., Yamauchi, M., Okamoto, T., Suzuki, H., Ito, N., Fukumoto, S., Sugimoto, T., & Fujita, T. (2009) · Bone · doi:10.1016/j.bone.2009.06.017 · Cited by 153
Charytan, C., Coburn, J. W., Chonchol, M., et al. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.04.013 · Cited by 152
Lanthanum carbonate reduces FGF23 in chronic kidney disease Stage 3 patients
González‐Parra, E., González‐Casaus, M. L., Galan, A., Martínez-Calero, A., Navas, V., Rodríguez, M., & Ortíz, A. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr144 · Cited by 152
Seiler, S., Cremers, B., Rebling, N. M., Hornof, F., Jeken, J., Kersting, S., Steimle, C., Ege, P., Fehrenz, M., Rogacev, K. S., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr215 · Cited by 148
López, I., Rodríguez-Ortiz, M. E., Almadén, Y., Guerrero, F., de, A. M., Pineda, C., Shalhoub, V., Rodríguez, M., & Aguilera‐Tejero, E. (2011) · Kidney International · doi:10.1038/ki.2011.107 · Cited by 146
Yılmaz, M. İ., Sönmez, A., Sağlam, M., Yaman, H., Kılıç, S., Eyileten, T., Çağlar, K., Oğuz, Y., Vural, A., Yenicesu, M., et al. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.11.007 · Cited by 140
Koiwa, F., Kazama, J. J., Tokumoto, A., Onoda, N., Kato, H., Okada, T., Nii‐Kono, T., Fukagawa, M., & Shigematsu, T. (2005) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2005.00293.x · Cited by 138
Koizumi, M., Komaba, H., Nakanishi, S., Fujimori, A., & Fukagawa, M. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr384 · Cited by 136
Effect of acute changes of serum phosphate on fibroblast growth factor (FGF)23 levels in humans
Ito, N., Fukumoto, S., Takeuchi, Y., Takeda, S., Suzuki, H., Yamashita, T., & Fujita, T. (2007) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-007-0779-3 · Cited by 132
Mechanism of FGF23 processing in fibrous dysplasia
Bhattacharyya, N., Wiench, M., Dumitrescu, C. E., Connolly, B. M., Bugge, T. H., Patel, H. V., Gafni, R. I., Cherman, N., Cho, M., Hager, G. L., et al. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1546 · Cited by 130
Bacchetta, J., Dubourg, L. D., Harambat, J., Ranchin, B., Abou-Jaoudé, P., Arnaud, S., Carlier, M.-C., Richard, M., & Cochat, P. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1576 · Cited by 123
Stubbs, J. R., He, N., Idiculla, A., Gillihan, R., Liu, S., David, V., Hong, Y., & Quarles, L. D. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.516 · Cited by 113
FGF-23 and sFRP-4 in Chronic Kidney Disease and Post-Renal Transplantation
Pande, S., Ritter, C. S., Rothstein, M., Wiesen, K., Vassiliadis, J., Kumar, R., Schiavi, S. C., Slatapolsky, E., & Brown, A. J. (2006) · Nephron Physiology · doi:10.1159/000093277 · Cited by 108
Bone Formation Regulates Circulating Concentrations of Fibroblast Growth Factor 23
Samadfam, R., Richard, C., Nguyen‐Yamamoto, L., Bolivar, I., & Goltzman, D. (2009) · Endocrinology · doi:10.1210/en.2009-0472 · Cited by 106
Taylor, E. N., Rimm, E. B., Stampfer, M. J., & Curhan, G. C. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.02.012 · Cited by 103
Fibroblast Growth Factor-23 Is Regulated by 1α,25-Dihydroxyvitamin D
Collins, M. T., Lindsay, J. R., Jain, A., Kelly, M. H., Peck, C. M. C., Weinstein, L. S., Liu, J., Fedarko, N. S., & Winer, K. K. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050718 · Cited by 100
A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease
Isakova, T., Gutiérrez, O. M., & Wolf, M. S. (2009) · Kidney International · doi:10.1038/ki.2009.246 · Cited by 99
Self-citationKırkpantur, A., Balcı, M. M., Gürbüz, O. A., Afşar, B., Canbakan, B., Akdemir, R., & Aylı, M. D. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq539 · Cited by 96
Roos, M., Lutz, J., Salmhofer, H., Luppa, P. B., Knauß, A., Braun, S., Martinof, S., Schömig, A., Heemann, U. W., Kastrati, A., et al. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03074.x · Cited by 94
Gene expression analysis of kidneys from transgenic mice expressing fibroblast growth factor-23
Marsell, R., Krajisnik, T., Göransson, H., Ohlsson, C., Ljunggren, Ö., Larsson, T. E., & Jonsson, K. B. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm672 · Cited by 94
FGF23 and the parathyroid glands
Silver, J., & Naveh‐Many, T. (2010) · Pediatric Nephrology · doi:10.1007/s00467-010-1565-3 · Cited by 90
Elevated FGF 23 and phosphorus are associated with coronary calcification in hemodialysis patients
Srivaths, P. R., Goldstein, S. L., Silverstein, D. M., Krishnamurthy, R., & Brewer, E. D. (2011) · Pediatric Nephrology · doi:10.1007/s00467-011-1822-0 · Cited by 89
Fibroblast Growth Factor 23 in Patients Undergoing Peritoneal Dialysis
Isakova, T., Xie, H., Barchi-Chung, A., Vargas, G. S., Sowden, N., Houston, J., WAHL, P. W., Lundquist, A. L., Epstein, M., Smith, K., et al. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04290511 · Cited by 88
Self-citationPavik, I., Jaeger, P., Kistler, A. D., Poster, D., Krauer, F., Cavelti‐Weder, C., Rentsch, K., Wuthrich, R. P., & Serra, A. L. (2010) · Kidney International · doi:10.1038/ki.2010.375 · Cited by 87
Manghat, P., Fraser, W. D., Wierzbicki, A. S., Fogelman, I., Goldsmith, D. J. A., & Hampson, G. (2009) · Osteoporosis International · doi:10.1007/s00198-009-1142-4 · Cited by 84
Finch, J. L., Tokumoto, M., Nakamura, H. K., Yao, W., Shahnazari, M., Lane, N. E., & Slatopolsky, E. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00552.2009 · Cited by 81
WAHL, P. W., Xie, H., Scialla, J. J., Anderson, C. A. M., Bellovich, K. A., Brecklin, C. S., Chen, J., Feldman, H. I., Gutiérrez, O. M., Lash, J., et al. (2012) · Diabetes Care · doi:10.2337/dc11-2235 · Cited by 78
Self-citationFGF23 or PTH: which comes first in CKD ?
Isakova, T., & Wolf, M. S. (2010) · Kidney International · doi:10.1038/ki.2010.281 · Cited by 77
Self-citationWesseling‐Perry, K., Harkins, G. C., Wang, H.-J., Elashoff, R. M., Gales, B., Horwitz, M. J., Stewart, A. F., Jüppner, H., & Salusky, I. B. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1909 · Cited by 77
Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease
van Husen, M., Fischer, A., Lehnhardt, A., Klaassen, I., Möller, K., Müller-Wiefel, D. E., & Kemper, M. J. (2010) · Kidney International · doi:10.1038/ki.2010.107 · Cited by 76
Olauson, H., Qureshi, A. R., Miyamoto, T., Barany, P. F., Heimbürger, O., Lindholm, B., Stenvinkel, P., & Larsson, T. E. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq191 · Cited by 76
Takeda, Y., Komaba, H., Goto, S., Fujii, H., Umezu, M., Hasegawa, H., Fujimori, A., Nishioka, M., Nishi, S., & Fukagawa, M. (2011) · American Journal of Nephrology · doi:10.1159/000327019 · Cited by 68
Tencza, A. L., Ichikawa, S., Dang, A., Kenagy, D. N., McCarthy, E. F., Econs, M. J., & Levine, M. A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1535 · Cited by 64
Predictors of Sudden Cardiac Death
Shastri, S., Tangri, N., Tighiouart, H., Beck, G. J., Vlagopoulos, P. T., Ornt, D. B., Eknoyan, G., Kusek, J. W., Herzog, C. A., Cheung, A. K., et al. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06320611 · Cited by 60
Hansen, D., Rasmussen, K., Pedersen, S. M., Rasmussen, L. M., & Brandi, L. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr668 · Cited by 58
The impact of diabetes mellitus on vitamin D metabolism in predialysis patients
Tanaka, H., Hamano, T., Fujii, N., et al. (2009) · Bone · doi:10.1016/j.bone.2009.07.016 · Cited by 57
Daily Variability in Mineral Metabolites in CKD and Effects of Dietary Calcium and Calcitriol
Isakova, T., Xie, H., Barchi-Chung, A., Smith, K., Sowden, N., Epstein, M., Collerone, G., Keating, L., Jüppner, H., & Wolf, M. S. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11721111 · Cited by 49
Self-citationRenal Phosphate Loss in Long-Term Kidney Transplantation
Sirilak, S., Chatsrisak, K., Ingsathit, A., Kantachuvesiri, S., Sumethkul, V., Stitchantrakul, W., Radinahamed, P., & Disthabanchong, S. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06380611 · Cited by 47
Gutiérrez, O., & Wolf, M. (2010) · Seminars in dialysis · doi:10.1111/j.1525-139x.2010.00750.x · Cited by 43
Self-citationResidual renal function is an independent determinant of serum FGF-23 levels in dialysis patients
Viaene, L., Bammens, B., Meijers, B. K. I., Vanrenterghem, Y. F. C., Vanderschueren, D., & Evenepoel, P. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr596 · Cited by 43
Yu, Y. M., Sanderson, S. R., Reyes, M., Sharma, A., Dunbar, N., Srivastava, T., Jüppner, H., & Bergwitz, C. (2012) · Bone · doi:10.1016/j.bone.2012.02.015 · Cited by 42
'Dem bones' are made for more than walking
Quarles, L. D. (2011) · Nature Medicine · doi:10.1038/nm0411-428 · Cited by 42
Elevated Fibroblast Growth Factor 23 in Women With Malignant Ovarian Tumors
Tebben, P. J., Kalli, K. R., Cliby, W. A., Hartmann, L. C., Grande, J. P., Singh, R. J., & Kumar, R. (2005) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)61528-0 · Cited by 41
Stevens, K. K., McQuarrie, E. P., Sands, W., Hillyard, D. Z., Patel, R. K., Mark, P. B., & Jardine, A. G. (2011) · International Journal of Nephrology · doi:10.4061/2011/297070 · Cited by 37
Canziani, M. E. F., Tomiyama, C., Higa, A., Draibe, S. A., & Carvalho, A. B. (2010) · Blood Purification · doi:10.1159/000321368 · Cited by 36
Effects of gonadal steroid withdrawal on serum phosphate and FGF-23 levels in men
Burnett‐Bowie, S. M., Mendoza, N., & Leder, B. Z. (2006) · Bone · doi:10.1016/j.bone.2006.10.016 · Cited by 36
Zisman, A. L., & Wolf, M. (2010) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e328338f536 · Cited by 31
Self-citationSchiavi, S. C. (2006) · Nature Genetics · doi:10.1038/ng1106-1230 · Cited by 24
PTH, FGF23, and calcium: it takes three to tango?
Evenepoel, P., Viaene, L., & Meijers, B. K. I. (2011) · Kidney International · doi:10.1038/ki.2011.350 · Cited by 13
Cited by
Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy
Grabner, A., Amaral, A. P., Schramm, K., Singh, S., Sloan, A., Yanucil, C., Li, J., Shehadeh, L. A., Hare, J. M., David, V., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.09.002 · Cited by 541
Self-citationFibroblast Growth Factor-23 and Cardiovascular Events in CKD
Scialla, J. J., Xie, H., Rahman, M., Anderson, A. H., Isakova, T., Ojo, A., Zhang, X., Nessel, L., Hamano, T., Grunwald, J. E., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013050465 · Cited by 445
Self-citationWiggins, J. E., Goyal, M., Sanden, S. K., Wharram, B. L., Shedden, K. A., Misek, D. E., Kuick, R. D., & Wiggins, R. C. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005050488 · Cited by 350
Genovese, F., Manresa, A. A., Leeming, D. J., Karsdal, M. A., & Boor, P. (2014) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-7-4 · Cited by 337
FGF23 signaling impairs neutrophil recruitment and host defense during CKD
Rossaint, J., Oehmichen, J., Van Aken, H., Reuter, S., Pavenstädt, H. J., Meersch, M., Unruh, M., & Zarbock, A. (2016) · Journal of Clinical Investigation · doi:10.1172/jci83470 · Cited by 276
Metadata
- Authors
- Wolf, M.
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 2012-10
- Volume
- 82
- Issue
- 7
- Pages
- 737-747
- ISSN
- 0085-2538 (ISSN-L)
- OpenAlex
- W1983098935
- Cited by
- 391
- References
- 145
- FWCI
- 28.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.